Mount Sinai Medical Center - Emergency Medicine

Links shared publicly online about this topic.

  • 1,286
    total visits

Mount Sinai Medical Center - Emergency Medicine

mountsinai.org

Mount Sinai Medical Center - Emergency Medicine

View full resource at mountsinai.org

Tags: Emergency, Mount Sinai Medical Center, Emergency Medicine

  • Share

Most Recently Shared on March 26, 2010 at 11:50 pm By:

timlawler timlawler

Mount Sinai Medical Center - Emergency Medicine http://bit.ly/b6LUQ0

2 years ago...

David H. Koch Donates $10 Million to Mount Sinai’s Jaffe Food Allergy Institute

newswise.com — “David H. Koch, Executive Vice President of Koch Industries, has committed $10 million to the Jaffe Food Allergy Institute at The Mount Sinai Medical Center. The gift is one of the largest in the Institute's history and will create the David H. and Julia Koch Research Program in Food Allergy Therapeutics. The program will serve as a hub for drug discovery and vaccine development related to food allergy, and build upon the promising work already underway at the Institute. The donation will also beView full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on April 11, 2012 at 10:46 pm By:

unhealthytruth Robyn O'Brien Health Executive

David Koch gives $10 million to fund research on drug discovery & vaccine development related to #foodallergy http://t.co/90ilZOYP #fixfood

1 month ago...

David H. Koch donates $10 million to Mount Sinai's Jaffe Food Allergy Institute

eurekalert.org — “David H. Koch, Executive Vice President of Koch Industries, has committed $10 million to the Jaffe Food Allergy Institute at the Mount Sinai Medical Center. The gift is one of the largest in the Institute's history and will create the David H. and Julia Koch Research Program in Food Allergy Therapeutics.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on April 10, 2012 at 3:49 pm By:

GlutenFreeAdvic Gluten Free

http://t.co/jtsvyWg7 David H. Koch donates $10 million to Mount Sinai's Jaffe Food Allergy Institute - EurekAler... http://t.co/02rakyBV

1 month ago...

Ob/Gyn Visit a Good Time to Screen for Heart Disease: Study - Drugs.com MedNews

drugs.com — “during routine visits to obstetrics and gynecology clinics, a new study suggests. Researchers from Mount Sinai Medical Center in New York City found that heartView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 5:10 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Ob/Gyn Visit a Good Time to Screen for Heart Disease: Study: MONDAY, March 26 -- Women should be screened ... http://t.co/OYqJStQK #drug

2 months ago...

Food Allergy Expert Coming to Darien - Darien, CT Patch

darien.patch.com — “Dr. Sampson is an internationally renowned expert and Director of the Jaffe Food Allergy Institute at New York’s Mount Sinai Medical Center. He will be discussing potential new therapies that could prevent life-threatening allergic reactions.View full resource at darien.patch.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 8:19 pm By:

New York City Agrees To Turn Over 9/11 Health Information To Mount Sinai Medical Center « CBS New York

newyork.cbslocal.com — “Pending a confidentiality agreement, the health information of more that 300 police department personnel who developed cancer after working at the World Trade Center site will be given to Mount Sinai Medical Center. News, Sports, Weather, Traffic and the Best of NYView full resource at newyork.cbslocal.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 4:00 am By:

Healthy4you Mark Erichsen Health Advocate

City Agrees To Turn Over 9/11 Health Information To Mount Sinai: New York City, pending a confidentiality agreem... http://t.co/nnHA1IWH

2 months ago...

Actinic Keratosis Treatment Newly On Prescription - QualityPoint Technologies

qualitypointtech.net — “A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine. The gel, called ingenol mebutate, is applied to the skin for just a few days, making it quicker and even more effective as current therapies require weeks to months to apply. The Phase III study results of the trial are publisView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on March 18, 2012 at 10:45 am By:

MedicalFeed MedicalFeed Health News Feed

Actinic Keratosis Treatment Newly On Prescription: A new topical gel now available by prescription significantly d... http://t.co/o8lB9WQ2

2 months ago...

Robotic Prostate Surgery Details - YouTube

youtube.com — “Mt. Sinai Medical Center's Dr. David Samadi gives a glimpse into one man's choice to have robotic prostatectomy surgery following his early prostate cancer d...View full resource at youtube.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 12:30 am By:

drdavidsamadi David Samadi, M.D. Doctor, Surgeon, Urologist, and Physician

Robotic Prostate Surgery Details: http://t.co/hVNS7pYR via @youtube Smart(samadi modified advanced robotic technique) at Mount Sinai medical

2 months ago...

New topical gel decreases amount of time needed to treat actinic keratosis

news-medical.net — “A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 7:53 am By:

NewsMedical News-Medical.Net Health News

New topical gel decreases amount of time needed to treat actinic keratosis: A new topical gel now available by p... http://t.co/BHooPNFH

2 months ago...

New drug now available for actinic keratosis

medicalxpress.com — “A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine. The gel, called ingenol mebutate, ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 10:17 pm By:

New Drug Now Available for Actinic Keratosis, a Common Pre-Cancerous Skin Condition

newswise.com — “A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine. The gel, called ingenol mebutate, is applied to the skin for just a few days, making it quicker and even more effective as current therapies require weeks to months to apply. The Phase III study results of the trial are publisView full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 8:38 pm By:

newswise newswise Health Communicator and Health News

New Drug Now Available for Actinic Keratosis, a Common Pre-Cancerous Skin Condition http://t.co/IzsuPSgS

2 months ago...

New Drug Now Available for Actinic Keratosis, a Common Pre-Cancerous Skin Condition

newswise.com — “A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine. The gel, called ingenol mebutate, is applied to the skin for just a few days, making it quicker and even more effective as current therapies require weeks to months to apply. The Phase III study results of the trial are publisView full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 8:30 pm By:

mednewswise Thom Canalichio Health News

#health news: New Drug Now Available for Actinic Keratosis, a Common Pre-Cancerous Skin Condition http://t.co/zB2EtaB5

2 months ago...

Brain injury and depression - YouTube

youtube.com — “The Brain Injury Research Center of the Mount Sinai School of Medicine produced this educational video on depression that may occur after brain injury. For m...View full resource at youtube.com

  • View Related
  • Share

Most Recently Shared on March 13, 2012 at 2:06 pm By:

brainline BrainLine Health Organization

I added a video to a @YouTube playlist http://t.co/wOAB05E2 Brain injury and depression

2 months ago...

Finding peace with medicine - TownNEWS - MyTownCrier.ca - the online home of Toronto's Town Crier Group of Community Newspapers

mytowncrier.ca — “MyTownCrier.ca PHOTO COURTESY DITAS REYESBUILDING BRIDGES: Medical students from Israel, Palestine, Jordan and Canada take part in a program at Sick Kids, ...View full resource at mytowncrier.ca

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 7:35 pm By:

Stemming the tide of overtreatment in U.S. healthcare | Reuters

reuters.com — “CHICAGO (Reuters) - A leading group of U.S. doctors is trying to tackle the costly problem of excessive medical testing, hoping to avoid more government intervention in how they practice.The AmericanView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on February 16, 2012 at 3:27 pm By:

Workers and 9/11 Responders Mourn Passing of Dr. Stephen Levin | EHS Today

ehstoday.com — “Dr. Stephen Levin, former medical director of Mount Sinai Medical Center?s Irving J. Selikoff Occupational and Environmental Medical Center and a long-time advocate for workers, has died of cancer. He was 70 years old.View full resource at ehstoday.com

  • View Related
  • Share

Most Recently Shared on February 10, 2012 at 8:53 pm By:

EHSToday EHS Today Health Magazine

Workers and 9/11 responders mourn the passing of Dr. Stephen Levin: http://t.co/rcCSzic9

3 months ago...

Advertisement